HLI
$140.70+1.19 (+0.85%)
Houlihan Lokey, Inc., an investment banking company, provides merger and acquisition (M&A), capital market, financial restructurings and liability management, and financial and valuation advisory services worldwide.
Intraday
Recent News
How The Evolving Investment Narrative Is Reframing Helia Group’s (ASX:HLI) Fair Value Story
Helia Group’s consensus analyst fair value has shifted slightly, with the target moving from A$4.35 to about A$4.27 per share. This trim lines up with broader research across financial services, where analysts are adjusting targets but not treating Helia as an outlier. As you read on, you will see how this evolving narrative might shape the way you track Helia’s story from here. Stay updated as the Fair Value for Helia Group shifts by adding it to your watchlist or portfolio. Alternatively,...
Affirm, Houlihan Lokey, Shift4, Fiserv, and Paymentus Stocks Trade Down, What You Need To Know
A number of stocks fell in the afternoon session after investors raised concerns over the stability of the private credit market, following a key announcement from a major bank.
Medtech industry value to be driven by infrastructure over next decade
Analysis by Houlihan Lokey suggests that healthcare institutions are favouring medical equipment that readily fits in with their existing systems.
Houlihan Lokey, State Street, Stifel, Blackstone, and TPG Shares Plummet, What You Need To Know
A number of stocks fell in the afternoon session after the release of a surprisingly weak February jobs report showed an unexpected drop in employment.
A Look At Houlihan Lokey (HLI) Valuation After Recent Share Price Weakness
What Houlihan Lokey's Recent Share Performance Signals for Investors Houlihan Lokey (HLI) has drawn fresh attention after a period of weaker share performance, with the stock showing a 2.6% decline over the past day and a 12.5% decline over the past 3 months. See our latest analysis for Houlihan Lokey. At a share price of US$157.30, Houlihan Lokey’s recent 1 day and 7 day share price declines sit against a modest 1 year total shareholder return of 1.35% and a much stronger 83.26% total...